国际肺癌研究协会建议的N描述符验证研究
本研究在1228例病理N1或N2的非小细胞肺癌患者中验证国际肺癌研究协会(IASLC)新提出的N描述符(结合转移淋巴结位置、单站或多站、跳跃转移)的区分能力和预后表现。结果显示五个亚组(N1a、N1b、N2a1、N2a2、N2b)的5年总生存率存在重叠,N2a1与N1a/N1b区分不足,N1b与N2a2区分不足。作者建议将预后相似的组别合并为三或四组,并需大规模前瞻性研究验证。
要点
- IASLC新N描述符五个亚组预后有重叠,区分能力有限。
- N2a1与N1a/N1b总生存区分不足,N1b与N2a2亦区分不足。
- 建议将相似预后组合并为三或四组,需前瞻性验证。
核心结论
- IASLC提出的新N描述符五个亚组预后意义存在重叠,建议合并为三或四组以提高区分度。
研究设计与样本
- 回顾性队列研究,纳入2004至2014年间接受主要肺切除术且病理确诊为N1或N2的非小细胞肺癌患者1228例。
主要发现
- N1a、N1b、N2a1、N2a2、N2b的5年总生存率分别为62.6%、57.0%、64.7%、48.4%、42.8%。
- 总生存和无复发生存分析显示N2a1与N1a和N1b区分不足。
- 总生存分析显示N1b与N2a2区分不足。
关键数值与推荐
- 中位清扫淋巴结总数为24枚(范围10-83),中位受累淋巴结数为2枚(范围1-40)。
临床怎么用
- 临床分期或预后评估时需注意IASLC新N描述符各亚组间存在预后重叠,不宜过度依赖细分组。
局限性
- 为单中心回顾性研究,需大规模前瞻性研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: The International Association for the Study of Lung Cancer recently proposed a new N descriptor by combining the location of metastatic lymph nodes (LNs), nN (single-station versus multiple-station), and absence versus presence of skip metastasis as pN1a, pN1b, pN2a1, pN2a2 and pN2b. This study aimed to evaluate the discriminatory ability and prognostic performance of the proposed N descriptor in a large independent NSCLC cohort. METHODS: We analyzed 1228 patients who underwent major pulmonary resection for pathological N1 or N2 NSCLC between 2004 and 2014. Survival analysis using the Cox proportional hazard model was performed to assess the prognostic significance of the N descriptor. RESULTS: From 2004 to 2014, a total of 7437 patients were operated on for NSCLC. Patients pathologically confirmed as having N1 (n = 732) or N2 (n = 496) disease after surgery were included. The median total number of dissected LNs was 24 (range 10-83), and the median number of involved LNs was 2 (range 1-40). The 5-year overall survival rates were 62.6%, 57.0%, 64.7%, 48.4%, and 42.8% for stages N1a, N1b, N2a1, N2a2, and N2b, respectively. Analysis of overall and recurrence-free survival revealed that N2a1 is not sufficiently distinguished from N1a and N1b. In terms of overall survival, N1b is not sufficiently distinguished from N2a2. CONCLUSION: On the basis of the N descriptor proposed by the International Association for the Study of Lung Cancer, some of the prognostic implications of the five groups overlapped. It would be better to classify similar prognostic groups into three or four groups to divide the group. A large-scale prospective study is needed to validate these N descriptors.
引用
- Park BJ, Kim TH, Shin S, et al. Recommended Change in the N Descriptor Proposed by the International Association for the Study of Lung Cancer: A Validation Study. J Thorac Oncol. 2019. PMID: 31442497. doi:10.1016/j.jtho.2019.07.034
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。